Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial
Clinical trial NCT05333458 · RECRUITING
Trial details
- NCT number
- NCT05333458
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-29
- Primary completion
- 2027-05-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.